CD8A and cancer: After intratumoral infiltration primed CD8+ T cells must recognize specific tumor neoantigens (TNAs, which are not covered by central tolerance) or tumor-associated antigens (TAAs, for which central tolerance is leaky) bound to MHC I on cancer cells [36].